Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CELG > SEC Filings for CELG > Form 8-K on 13-Jun-2013All Recent SEC Filings

Show all filings for CELGENE CORP /DE/ | Request a Trial to NEW EDGAR Online Pro

Form 8-K for CELGENE CORP /DE/


Change in Directors or Principal Officers, Submission of Matters to a Vote of S


(e) At the annual meeting of stockholders (the "Annual Meeting") of Celgene Corporation (the "Company") held on June 12, 2013, the Company's stockholders approved an amendment and restatement of the Company's 2008 Stock Incentive Plan (the "Plan") to, among other things:

Adopt an aggregate share reserve of 104,981,641 shares of our Common Stock. This number includes our current share reserve of 95,981,641 shares of our Common Stock and 9,000,000 additional new shares of our Common Stock.

Increase the maximum payment to an eligible employee under a cash-based performance award from $4,000,000 to $6,000,000 (prorated if the performance period is less than three consecutive fiscal years).

Extend the term of the Plan through April 17, 2023.

The Plan also includes certain changes that became effective April 17, 2013 and do not require stockholder approval. These changes include: (i) a revision to the definition of "retirement" to include a "Rule of 65" (age plus years of service totaling at least 65) with a minimum of two years of service and
(ii) clarifications to provisions relating to Section 409A of the Internal Revenue Code relating to deferred compensation.

In addition to the foregoing, our stockholders reapproved the Section 162(m) performance goals under the Plan so that certain incentive awards granted under the Plan to executive officers of the Company may qualify as exempt performance-based compensation under Section 162(m) of the Internal Revenue Code.

The foregoing is a brief summary of the principal provisions of the amendments to the Plan and does not purport to be complete and is qualified in its entirety by reference to the full text of the Plan, as amended and restated, which Amended and Restated Plan is attached as Exhibit 10.1 and incorporated herein by reference.


(a) The annual meeting of stockholders of the Company was held on June 12, 2013.

(b) Stockholders voted on the matters set forth below:

Proposal 1. Election of Directors:

                                          For            Against         Withheld         Broker Non-Votes
Robert J. Hugin                        269,728,914            N/A        31,230,784              55,460,890
Richard W. Barker, D.Phil.             275,600,140            N/A        25,359,558              55,460,890
Michael D. Casey                       246,446,675            N/A        54,513,023              55,460,890
Carrie S. Cox                          275,067,124            N/A        25,892,574              55,460,890
Rodman L. Drake                        247,739,725            N/A        53,219,973              55,460,890
Michael A. Friedman, M.D.              247,687,357            N/A        53,272,341              55,460,890
Gilla Kaplan, Ph.D.                    273,764,942            N/A        27,194,756              55,460,890
James J. Loughlin                      273,555,246            N/A        27,404,452              55,460,890
Ernest Mario, Ph.D.                    214,282,570            N/A        86,677,128              55,460,890

Proposal 2. Ratification of Appointment of KPMG LLP as the Company's Independent
Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2013:

                         For                  350,892,707
                         Against                4,282,652
                         Abstain                1,245,229
                         Broker Non-Votes               0

Proposal 3. Amendment and Restatement of the Company's 2008 Stock Incentive Plan (the description of the amendments to the Plan contained in Item 5.02 of this Current Report on Form 8-K is incorporated herein by reference):

                         For                  241,943,073
                         Against               58,595,008
                         Abstain                  421,617
                         Broker Non-Votes      55,460,890

Proposal 4. Advisory Vote on Executive Compensation:

                         For                  282,109,517
                         Against               18,324,147
                         Abstain                  526,034
                         Broker Non-Votes      55,460,890

Proposal 5. Advisory Vote on Stockholder Proposal (described in more detail in the Proxy Statement). The proposal was not introduced by the proponent or his representative and therefore was not properly before the meeting for vote. However, had the proposal been properly introduced, it would not have received a majority of the votes cast.

(c) Not applicable.

(d) Not applicable.


On June 12, 2013, the Company issued a press release announcing the authorization of the repurchase of up to an additional $3.0 billion of the Company's common stock. Purchases may be made in the open market or in privately negotiated transactions from time to time, as determined by the Company's management and in accordance with applicable requirements of the Securities and Exchange Commission. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, that is furnished pursuant to this Item 7.01 shall not be deemed to be "filed" for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


(d) Exhibits

10.1     Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of
         April 17, 2013)

99.1     Press Release dated June 12, 2013. This exhibit is furnished pursuant to
         Item 7.01 and shall not be deemed to be "filed."

  Add CELG to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CELG - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.